New-Onset Type 2 Diabetes Mellitus in Critical Illness Survivors and after Hospitalization
This study highlights the high rate of NODM2 development after hospitalization. Growing evidence suggests that it may lead to long-term metabolic complications, particularly in patients who experienced dysglycemia during illness.
Authors
- Marko Nemet (ORCID: https://orcid.org/0000-0003-1485-9214)
- Leslie C. Hassett (ORCID: https://orcid.org/0000-0002-1889-8387)
- Aysun Tekin (ORCID: https://orcid.org/0000-0002-1891-2118)
- Juan García-Méndez
- İbrahim Serhat Karakuş (ORCID: https://orcid.org/0000-0002-7930-4001)
- Oğuz Kılıçkaya
- Amos Lal
- S. Abramovich
- Diksha Mahadeva Gowda
- Gabriele Alves Halpern
Institutions
- Mayo Clinic (US)
- WinnMed (US)
- Methodist Hospital (US)
- Pulmonary and Critical Care Associates (US)
Publication Details
- Journal
- Southern Medical Journal
- Published
- 2025-12-01
- DOI
- https://doi.org/10.14423/smj.0000000000001904
- Primary Topic
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Type
- article
- Field-Weighted Citation Impact
- 0.00